Verona Pharma plc (VRNA): A Bull Case Theory [Yahoo! Finance]
Verona Pharma plc - American Depositary Shares (VRNA)
US:NASDAQ Investor Relations:
nasdaq.com/symbol/vrna/real-time
Company Research
Source: Yahoo! Finance
Verona Pharma plc (VRNA)'s share was trading at $67.50 as of March 4 th . VRNA's forward P/E was 434.78 according to Yahoo Finance. A scientist working in a laboratory performing tests on a newly developed biotechnology drug. Verona Pharma (VRNA) has reported strong Q4 earnings, reinforcing the bullish case for its long-term growth. CEO Mark Hahn indicated that sales could approach $300 million in 2025, though the company refrained from issuing formal guidance. However, management did not contest the consensus estimate of $270 million and hinted at exceeding it. The company's lead product, Ohtuvayre, is emerging as a market mainstay, with growing adoption and refills expected to drive recurring revenue, mirroring the success of Trelegy
Read more
Impact Snapshot
Event Time:
VRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRNA alerts
High impacting Verona Pharma plc - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
VRNA
News
- Verona Pharma Announces Amended Strategic Financing with Oaktree and OMERSGlobeNewswire
- Verona Pharma plc (NASDAQ: VRNA) was given a new $83.00 price target on by analysts at Roth Capital.MarketBeat
- Verona Pharma plc (NASDAQ: VRNA) had its price target raised by analysts at Wells Fargo & Company from $74.00 to $93.00. They now have an "overweight" rating on the stock.MarketBeat
- Verona Pharma plc (NASDAQ: VRNA) had its price target raised by analysts at HC Wainwright from $60.00 to $75.00. They now have a "buy" rating on the stock.MarketBeat
- Verona Pharma PLC (VRNA) Q4 2024 Earnings Call Highlights: Strong Launch of Ohtuvayre Amid ... [Yahoo! Finance]Yahoo! Finance
VRNA
Sec Filings
- 3/28/25 - Form 8-K
- 3/18/25 - Form ARS
- 3/18/25 - Form DEF
- VRNA's page on the SEC website